Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in Myanmar has been experiencing steady growth in recent years.
Customer preferences: Myanmar's population has been increasingly aware of the importance of vaccination in preventing diseases. This trend is driven by the government's efforts in promoting vaccination campaigns and educating the public about the benefits of immunization. Additionally, the rising income levels and urbanization have led to an increase in demand for healthcare services, including vaccinations.
Trends in the market: The Other Vaccines market in Myanmar is dominated by multinational pharmaceutical companies that offer a wide range of vaccines. The market has been witnessing an increasing demand for vaccines that protect against infectious diseases such as hepatitis B, meningitis, and pneumococcal disease. This trend is driven by the government's efforts in expanding the national immunization program to cover more diseases and a larger population. Furthermore, the private sector has been playing an increasingly important role in the vaccination market, offering a wider range of vaccines and better accessibility for consumers.
Local special circumstances: Myanmar has a challenging healthcare system, with limited resources and infrastructure. The country has a high burden of infectious diseases, including tuberculosis, malaria, and dengue fever. The government has been working to improve the healthcare system and expand access to essential medicines, including vaccines. However, there are still significant challenges in reaching remote and rural areas, where the majority of the population lives.
Underlying macroeconomic factors: Myanmar has been experiencing rapid economic growth in recent years, driven by the opening up of the country and the implementation of economic reforms. The country's GDP has been growing at an average rate of 6-7% per year, and this growth is expected to continue in the coming years. The rising income levels and urbanization have led to an increase in demand for healthcare services, including vaccinations. However, there are still significant challenges in the healthcare sector, including limited resources and infrastructure, which may limit the growth of the Other Vaccines market in Myanmar.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
